These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Portfolio Pulse from Avi Kapoor
Repligen Corporation (NASDAQ:RGEN) reported in-line Q2 earnings with sales of $154.1 million and an adjusted EPS of 33 cents. The company expects 2024 revenues of $620 million—$635 million. Analysts revised their price targets: JP Morgan raised to $200, UBS cut to $185. Shares gained 5.3% to $169.16.

July 31, 2024 | 6:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repligen reported in-line Q2 earnings with sales of $154.1 million and an adjusted EPS of 33 cents. The company expects 2024 revenues of $620 million—$635 million. Analysts revised their price targets: JP Morgan raised to $200, UBS cut to $185. Shares gained 5.3% to $169.16.
Repligen's Q2 earnings were in line with expectations, and the company provided a slightly lower revenue guidance for 2024 compared to consensus. Despite mixed analyst price target revisions, the stock gained 5.3%, indicating positive market sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100